D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 85 Citations 32,232 343 World Ranking 9464 National Ranking 5028

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

His primary areas of study are Internal medicine, Gastroenterology, Hepatitis C, Cirrhosis and Ribavirin. His biological study spans a wide range of topics, including Surgery and Immunology. The study incorporates disciplines such as Adverse effect and Viral load in addition to Gastroenterology.

His Hepatitis C research incorporates elements of Hepatitis C virus, Viral hepatitis, Intensive care medicine, Hepatocellular carcinoma and Pharmacotherapy. His Hepatocellular carcinoma study integrates concerns from other disciplines, such as Carcinoma, Pathology and Ascites. His research integrates issues of Cytology and Liver biopsy in his study of Cirrhosis.

His most cited work include:

  • Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. (2656 citations)
  • A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST) (1138 citations)
  • A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus (655 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Gastroenterology, Hepatitis C, Cirrhosis and Ribavirin. The concepts of his Internal medicine study are interwoven with issues in Endocrinology, Immunology and Hepatitis C virus. His Hepatology study in the realm of Gastroenterology interacts with subjects such as In patient.

His Hepatitis C research integrates issues from Chronic liver disease, Interferon, Liver function tests and Pathology. Timothy R. Morgan has included themes like Liver function, Liver transplantation, Liver biopsy, Clinical trial and Liver cancer in his Cirrhosis study. His Ribavirin research is classified as research in Genotype.

He most often published in these fields:

  • Internal medicine (83.24%)
  • Gastroenterology (47.61%)
  • Hepatitis C (39.89%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (83.24%)
  • Hepatitis C (39.89%)
  • Veterans Affairs (4.79%)

In recent papers he was focusing on the following fields of study:

Timothy R. Morgan spends much of his time researching Internal medicine, Hepatitis C, Veterans Affairs, Alcoholic hepatitis and Cirrhosis. The various areas that Timothy R. Morgan examines in his Internal medicine study include Gastroenterology, MEDLINE and Alcohol use disorder. He studies Alanine aminotransferase, a branch of Gastroenterology.

His work deals with themes such as Nursing and Hepatitis C virus, which intersect with Hepatitis C. His Alcoholic hepatitis research also works with subjects such as

  • Steatohepatitis and related Cytokine, Hepatocellular carcinoma, Immunology, Insulin resistance and Nonalcoholic steatohepatitis,
  • Extracorporeal, Sorption Detoxification, Sobriety, After treatment and Heavy alcohol use most often made with reference to Liver transplantation. His Cirrhosis study combines topics from a wide range of disciplines, such as Decompensation, Endocrinology, Obesity, Carcinogenesis and Hypertriglyceridemia.

Between 2016 and 2021, his most popular works were:

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. (270 citations)
  • Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection (115 citations)
  • Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. (72 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Timothy R. Morgan mainly investigates Internal medicine, Odds ratio, Hepatitis C virus, Cirrhosis and Hepatitis C. His Internal medicine research is multidisciplinary, relying on both Magnetic resonance imaging and Cardiac magnetic resonance imaging. His work carried out in the field of Odds ratio brings together such families of science as Clinical trial, Genome-wide association study, Disease, Diagnosis code and Cohort.

In general Hepatitis C virus study, his work on Sofosbuvir often relates to the realm of Member states, thereby connecting several areas of interest. His Hepatitis C study combines topics in areas such as Population health, Population Health Management and MEDLINE. His Ribavirin study deals with Veterans Affairs intersecting with Nursing and System redesign.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Hadziyannis Sj;Sette H;Morgan Tr;Balan.
Annals of Internal Medicine (2004)

3932 Citations

A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST)

Walter H. Ettinger;Robert Burns;Stephen P. Messier;William Applegate.
JAMA (1997)

1878 Citations

The natural history of hepatitis C virus (HCV) infection.

Stephen L. Chen;Timothy R. Morgan.
International Journal of Medical Sciences (2006)

1039 Citations

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

Ludmila Prokunina-Olsson;Brian Muchmore;Wei Tang;Ruth M Pfeiffer.
Nature Genetics (2013)

976 Citations

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie.
Gastroenterology (2009)

742 Citations

Alcohol and hepatocellular carcinoma.

Timothy R. Morgan;Timothy R. Morgan;Sarathy Mandayam;Sarathy Mandayam;M. Mazen Jamal;M. Mazen Jamal.
Gastroenterology (2004)

688 Citations

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima.
Gastroenterology (2004)

658 Citations

A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins

John R. Crouse;Timothy Morgan;James G. Terry;Julie Ellis.
JAMA Internal Medicine (1999)

657 Citations

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy†‡§

Donald M. Jensen;Timothy R. Morgan;Patrick Marcellin;Paul J. Pockros.
Hepatology (2006)

649 Citations

Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial

Dalane W. Kitzman;Peter Brubaker;Timothy Morgan;Mark Haykowsky.
JAMA (2016)

643 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Timothy R. Morgan

Stefan Zeuzem

Stefan Zeuzem

Goethe University Frankfurt

Publications: 146

Jean-Michel Pawlotsky

Jean-Michel Pawlotsky

Université Paris Cité

Publications: 104

Mark S. Sulkowski

Mark S. Sulkowski

Johns Hopkins University School of Medicine

Publications: 92

Mitchell L. Shiffman

Mitchell L. Shiffman

Bon Secours Health System

Publications: 87

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 75

Kazuaki Chayama

Kazuaki Chayama

Hiroshima University

Publications: 74

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 74

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 71

Ira M. Jacobson

Ira M. Jacobson

New York University

Publications: 71

Hiromitsu Kumada

Hiromitsu Kumada

Fukuoka University

Publications: 69

Christoph Sarrazin

Christoph Sarrazin

Goethe University Frankfurt

Publications: 67

Antonio Craxì

Antonio Craxì

University of Palermo

Publications: 65

Peter Ferenci

Peter Ferenci

Medical University of Vienna

Publications: 63

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 62

Raymond T. Chung

Raymond T. Chung

Harvard University

Publications: 62

W. Jack Rejeski

W. Jack Rejeski

Wake Forest University

Publications: 60

Trending Scientists

Marek R. Ogiela

Marek R. Ogiela

AGH University of Science and Technology

Víctor Yepes

Víctor Yepes

Universitat Politècnica de València

John Christodoulou

John Christodoulou

University of Melbourne

Sergey V. Razin

Sergey V. Razin

Russian Academy of Sciences

Ray White

Ray White

University of Utah

Kazutoyo Osoegawa

Kazutoyo Osoegawa

Stanford University

James R. Sellers

James R. Sellers

National Institutes of Health

Guoyin Kai

Guoyin Kai

Zhejiang Chinese Medical University

John F. Prescott

John F. Prescott

University of Guelph

Gilles Gheusi

Gilles Gheusi

Institut Pasteur

Lisa F. P. Ng

Lisa F. P. Ng

Agency for Science, Technology and Research

Robert E. Tigelaar

Robert E. Tigelaar

Yale University

Tore Nielsen

Tore Nielsen

University of Montreal

Peter A. Ornstein

Peter A. Ornstein

University of North Carolina at Chapel Hill

Anthony J. Alberg

Anthony J. Alberg

University of South Carolina

Ron Blankstein

Ron Blankstein

Brigham and Women's Hospital

Something went wrong. Please try again later.